Patient-related and system-related barriers to glaucoma follow-up in a county hospital population

Investigative Ophthalmology and Visual Science

Volumn 54, Issue 10, 2013, Pages 6542-6548

  Lee, Bradford W ^a   Murakami, Yohko ^a   Duncan, Martin T ^a   Kao, Andrew A ^b   Huang, Jehn Yu ^b   Lin, Shan ^b   Singh, Kuldev ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Barriers to follow up; Clinical follow up; Compliance; Ethnicity

Indexed keywords

ADULT; AGED; ARTICLE; COMORBIDITY; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISEASE CONTROL; DISEASE SEVERITY; ETHNICITY; FEMALE; FOLLOW UP; GLAUCOMA; HEALTH CARE ACCESS; HEALTH CARE COST; HUMAN; MAJOR CLINICAL STUDY; MALE; PATIENT ATTITUDE; PILOT STUDY; PREVALENCE; PRIORITY JOURNAL; QUESTIONNAIRE; TREATMENT OUTCOME;

BARRIERS TO FOLLOW-UP; CLINICAL FOLLOW-UP; COMPLIANCE; ETHNICITY;

ADULT; AGED; AGED, 80 AND OVER; CROSS-SECTIONAL STUDIES; DELIVERY OF HEALTH CARE; ETHNIC GROUPS; FEMALE; FOLLOW-UP STUDIES; GLAUCOMA; HOSPITALS, COUNTY; HUMANS; MALE; MIDDLE AGED; MORBIDITY; PATIENT COMPLIANCE; PHYSICIAN-PATIENT RELATIONS; QUESTIONNAIRES; RETROSPECTIVE STUDIES; SAN FRANCISCO;

EID: 84885061934     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.13-12108     Document Type: Article

References (28)

1. Congdon N, O'Colmain B, Klayer CC, et al.; Eye Diseases Prevalence Research Group. Causes and prevalence of visual impairment among adults in the United States. Arch Ophthalmol. 2004;122:477-485.
2. Giangiacomo AC, Coleman AL. The epidemiology of glaucoma. In: Grehn F, Stamper R, eds. Glaucoma. Berlin-Heidelberg: Springer; 2009:13-21.
3. Friedman DS, Wolfs RC, O'Colmain BJ, et al.; Eye Diseases Prevalence Research Group. Prevalence of open-angle glaucoma among adults in the United States. Arch Ophthalmol. 2004;122:532-538.
4. Heijl A, Leske MC, Bengtsson B, Hyman L, Hussein M; Early Manifest Glaucoma Trial Group. Reduction of intraocular pressure and glaucoma progression: results from the Early Manifest Glaucoma Trial. Arch Ophthalmol. 2002;120:1268-1279.
5. Leske MC, Heijl A, Hussein M, Bengtsson B, Hyman L, Komaroff E; Early Manifest Glaucoma Trial Group. Factors for glaucoma progression and the effect of treatment: the Early Manifest Glaucoma Trial. Arch Ophthalmol. 2003;121:48-56.
6. Lichter PR, Musch DC, Gillespie BW, et al.; CIGTS Study Group. Interim clinical outcomes in the Collaborative Initial Glaucoma Treatment Study (CIGTS) comparing initial treatment randomized to medications or surgery. Ophthalmology. 2001;108:1943-1953.
7. Kass MA, Heuer DK, Higginbotham EJ, et al. The Ocular Hypertension Treatment Study: a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma. Arch Ophthalmol. 2002;120:701-713.
8. Leske MC, Heijl A, Hyman L, Bengtsson B, Dong L, Yang Z; EMGT Group. Predictors of long-term progression in the Early Manifest Glaucoma Trial. Ophthalmology. 2007;114:1965-1972.
9. Kass MA, Gordon MO, Hoff MR, et al. Topical timolol administration reduces the incidence of glaucomatous damage in ocular hypertensive individuals: a randomized, doublemasked, long-term clinical trial. Arch Ophthalmol. 1989;107:1590-1598.
10. Friedman DS, Quigley HA, Gelb L, et al. Using pharmacy claims data to study adherence to glaucoma medications: methodology and findings of the Glaucoma Adherence and Persistence Study (GAPS). Invest Ophthalmol Vis Sci. 2007;48:5052-5057.
11. Tsai T, Robin AL, Smith JP III. An evaluation of how glaucoma patients use topical medications: a pilot study. Trans Am Ophthalmol Soc. 2007;105:29-35.
12. Robin AL, Novack GD, Covert DW, Crockett RS, Marcic TS. Adherence in glaucoma: objective measurements of once-daily and adjunctive medication use. Am J Ophthalmol. 2007;144:533-540.
13. Sleath B, Robin AL, Covert D, Byrd JE, Tudor G, Svarstad B. Patient-reported behavior and problems in using glaucoma medications. Ophthalmology. 2006;113:431-436.
14. Nordstrom BL, Friedman DS, Mozaffari E, Quigley HA, Walker AM. Persistence and adherence with topical glaucoma therapy. Am J Ophthalmol. 2005;140:598-606.
15. Ngan R, Lam DL, Mudumbai RC, Chen PP. Risk factors for noncompliance with follow-up among normal-tension glaucoma suspects. Am J Ophthalmol. 2007;144:310-311.
16. Kosoko O, Quigley HA, Vitale S, Enger C, Kerrigan L, Tielsch JM. Risk factors for noncompliance with glaucoma follow-up visits in a residents' eye clinic. Ophthalmology. 1998;105:2105-2111.
17. Lee BW, Sathyan P, John RK, Singh K, Robin AL. Predictors of and barriers associated with poor follow-up in patients with glaucoma in South India. Arch Ophthalmol. 2008;126:1448-1454.
18. Sommer A, Tielsch JM, Katz J, et al. Baltimore Eye Survey Research Group. Relationship between intraocular pressure and primary open angle glaucoma among white and black Americans: the Baltimore Eye Survey. Arch Ophthalmol. 1991;109:1090-1095.
19. Tielsch JM, Sommer A, Katz J, Royall RM, Quigley HA, Javitt J. Racial variations in the prevalence of primary open-angle glaucoma: the Baltimore Eye Survey. JAMA. 1991;266:369-374.
20. Quigley HA, West SK, Rodriguez J, Munoz B, Klein R, Snyder R. The prevalence of glaucoma in a population-based study of Hispanic subjects: Proyecto VER. Arch Ophthalmol. 2001;119:1819-1826.
21. Varma R, Ying-Lai M, Francis BA, et al.; Los Angeles Latino Eye Study Group. Prevalence of open-angle glaucoma and ocular hypertension in Latinos: the Los Angeles Latino Eye Study. Ophthalmology. 2004;111:1439-1448.
22. Smedley BD, Stith AY, Nelson AR, eds. Unequal Treatment: Confronting Racial and Ethnic Disparities in Health Care. Washington, DC: National Academies Press; 2003.
23. American Academy of Ophthalmology. Primary Open-Angle Glaucoma: Preferred Practice Pattern. San Francisco: American Academy of Ophthalmology; 2005.
24. Murakami Y, Lee BW, Duncan M, et al. Racial and ethnic disparities in adherence to glaucoma follow-up visits in a county hospital population. Arch Ophthalmol. 2011;129:872-878.
25. Unzueta M, Globe D, Wu J, Paz S, Azen S, Varma R; Los Angeles Latino Eye Study Group. Compliance with recommendations for follow-up care in Latinos: the Los Angeles Latino Eye Study. Ethn Dis. 2004;14:285-291.
26. Paz, SH, Varma R, Klein R, Wu J, Azen SP; Los Angeles Latino Eye Study Group. Noncompliance with vision care guidelines in Latinos with type 2 diabetes mellitus: the Los Angeles Latino Eye Study. Ophthalmology. 2006;113:1372-1377.
27. Morales LS, Varma R, Paz SH, et al; Los Angeles Latino Eye Study Group. Self-reported use of eye care among Latinos: the Los Angeles Latino Eye Study. Ophthalmology. 2010;117:207-215.
28. Kaplan CP, Eisenberg M, Erickson PI, Crane LA, Duffey S. Barriers to breast abnormality follow-up: minority, low-income patients' and their providers' view. Ethn Dis. 2005;15:720-726.